ARCHIVES

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

December 25, 2009

Communication Is Key To Clinical Trial Enrollment

June 30, 2006

Committee Drafts QRA Definition

November 19, 1982

In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending

June 13, 1980

ORI Withdraws Requirement For Research Ethics Courses.

February 23, 2001

Also in this 8-page issue: White House appoints Koch Industries executive David Koch to the National Cancer Advisory Board. He asks: “How can we make the NCI elephant dance like a ballerina?”

September 17, 2004